Back to Search Start Over

Characteristics and outcomes of patients hospitalized for COVID-19 in France: The Critical COVID-19 France (CCF) study

Authors :
Benjamin Perin
Orianne Weizman
Thibaut Pommier
C. Chaumont
Julie Pastiero
Théo Pezel
Vassili Panagides
Pascale Chemaly
Nathalie Noirclerc
A. Darmon
Marine Mevelec
Sophie Ribeyrolles
Gauthier Giordano
Cyril Zakine
Diane Chavignier
Victor Waldmann
Thomas Delmotte
Antoine Deney
Laura Geneste
Wassima Marsou
Willy Sutter
Thomas Levasseur
Joffrey Cellier
Antonin Trimaille
Guillaume Bonnet
C Fauvel
Nacim Ezzouhairi
Baptiste Duceau
Clément Karsenty
Iris Ma
Sabir Attou
Delphine Mika
Audrey Sagnard
Pierre Guilleminot
Ariel Cohen
Alexandre Gautier
Source :
Archives of Cardiovascular Diseases
Publication Year :
2021
Publisher :
Elsevier BV, 2021.

Abstract

Background: The coronavirus disease 2019 (COVID-19) pandemic has led to a public health crisis. Only limited data are available on the characteristics and outcomes of patients hospitalized for COVID-19 in France. Aims: To investigate the characteristics, cardiovascular complications and outcomes of patients hospitalized for COVID-19 in France. Methods: The Critical COVID-19 France (CCF) study is a French nationwide study including all consecutive adults with a diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection hospitalized in 24 centres between 26 February and 20 April 2020. Patients admitted directly to intensive care were excluded. Clinical, biological and imaging parameters were systematically collected at hospital admission. The primary outcome was in-hospital death. Results: Of 2878 patients included (mean ± SD age 66.6 ± 17.0 years, 57.8% men), 360 (12.5%) died in the hospital setting, of which 7 (20.7%) were transferred to intensive care before death. The majority of patients had at least one (72.6%) or two (41.6%) cardiovascular risk factors, mostly hypertension (50.8%), obesity (30.3%), dyslipidaemia (28.0%) and diabetes (23.7%). In multivariable analysis, older age (hazard ratio [HR] 1.05, 95% confidence interval [CI] 1.03−1.06; P < 0.001), male sex (HR 1.69, 95% CI 1.11−2.57; P = 0.01), diabetes (HR 1.72, 95% CI 1.12−2.63; P = 0.01), chronic kidney failure (HR 1.57, 95% CI 1.02−2.41; P = 0.04), elevated troponin (HR 1.66, 95% CI 1.11−2.49; P = 0.01), elevated B-type natriuretic peptide or N-terminal pro-B-type natriuretic peptide (HR 1.69, 95% CI 1.0004−2.86; P = 0.049) and quick Sequential Organ Failure Assessment score ≥ 2 (HR 1.71, 95% CI 1.12−2.60; P = 0.01) were independently associated with in-hospital death. Conclusions: In this large nationwide cohort of patients hospitalized for COVID-19 in France, cardiovascular comorbidities and risk factors were associated with a substantial morbi-mortality burden.

Details

ISSN :
18752136
Volume :
114
Database :
OpenAIRE
Journal :
Archives of Cardiovascular Diseases
Accession number :
edsair.doi.dedup.....4a3431d776bda2f9162207d503e72c68